For the first time, Medicare will cover GLP-1s for obesity-related weight loss, without any other medical conditions.
The new implants will be for weight loss in cats and dogs
The cash price for popular weight-loss medication Wegovy is dropping by 30% in the U.S. on Monday, according to Novo Nordisk.
The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.
Under the pending agreements, a month's supply of the drug would cost roughly $149.
New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.